Your browser doesn't support javascript.
loading
Associations of the fibrosis-4 index with left atrial low-voltage areas and arrhythmia recurrence after catheter ablation: cardio-hepatic interaction in patients with atrial fibrillation.
Yamada, Shinya; Kaneshiro, Takashi; Nodera, Minoru; Amami, Kazuaki; Nehashi, Takeshi; Oikawa, Masayoshi; Yamaki, Takayoshi; Nakazato, Kazuhiko; Ishida, Takafumi; Takeishi, Yasuchika.
Afiliação
  • Yamada S; Department of Cardiovascular Medicine Fukushima Medical University Fukushima Japan.
  • Kaneshiro T; Department of Arrhythmia and Cardiac Pacing Fukushima Medical University Fukushima Japan.
  • Nodera M; Department of Cardiovascular Medicine Fukushima Medical University Fukushima Japan.
  • Amami K; Department of Cardiovascular Medicine Fukushima Medical University Fukushima Japan.
  • Nehashi T; Department of Cardiovascular Medicine Fukushima Medical University Fukushima Japan.
  • Oikawa M; Department of Cardiovascular Medicine Fukushima Medical University Fukushima Japan.
  • Yamaki T; Department of Cardiovascular Medicine Fukushima Medical University Fukushima Japan.
  • Nakazato K; Department of Cardiovascular Medicine Fukushima Medical University Fukushima Japan.
  • Ishida T; Department of Cardiovascular Medicine Fukushima Medical University Fukushima Japan.
  • Takeishi Y; Department of Cardiovascular Medicine Fukushima Medical University Fukushima Japan.
J Arrhythm ; 40(3): 585-593, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38939777
ABSTRACT

Background:

The relationship between liver fibrosis and left atrial (LA) remodeling in atrial fibrillation (AF) remains uncertain. We examined the associations between the fibrosis-4 (FIB4) index, an indicator of liver fibrosis, and both LA low-voltage areas (LVAs) on electroanatomic mapping and AF recurrence postablation.

Methods:

We recruited 343 patients who underwent radiofrequency catheter ablation (RFCA) or cryoballoon ablation (CBA) for AF. First, the association between the FIB4 index and LA LVAs (<0.5 mV) was evaluated in RFCA using electroanatomic mapping (n = 214). Next, the utility of a FIB4 index ≥1.3, recommended cut-off value of liver fibrosis, was verified to assess the risk for AF recurrence in CBA without additional LVA ablation (n = 129).

Results:

Patients with a FIB4 index ≥1.3 had a higher prevalence of LA LVAs (>5 cm2) compared to those without. Additionally, the quantitative size of LVAs showed a positive correlation with the FIB4 index (R = .642, p < .001). In multivariate logistic models, a FIB4 index ≥1.3 was related to the presence of LVAs after adjusting for LA diameter, right atrial end-systolic area, and nonparoxysmal AF (odds ratio 2.508; p = 0.039). In CBA, AF recurrence rate was 13.1% during 3-12 months postablation. In multivariate Cox models, a FIB4 index ≥1.3 was an important predictor of AF recurrence (hazard ratio 3.796; p = .037), suggesting that LVAs might be associated with AF recurrence after CBA.

Conclusion:

The FIB4 index was a novel predictor of the existence of LA LVAs on electroanatomic mapping and AF recurrence after CBA.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article